Wang Yue, Alnwisi Sameh, Ke Min
Ophthalmology of Zhongnan Hospital of Wuhan University, Wuhan, HuBei Province, China.
Medicine (Baltimore). 2017 Dec;96(48):e8019. doi: 10.1097/MD.0000000000008019.
We performed a meta-analysis to determine the impact of mild, moderate, and severe visual field loss on quality of life (QoL) in patients with glaucoma.
A comprehensive literature search was performed using the PubMed, Excerpta Medica dateBASE and China National Knowledge Infrastructure databases to identify relevant articles published before June 30, 2016. Patients' QoL was measured using the Glaucoma Quality of Life-15 Questionnaire (GQL-15).
In total, 401 patients with glaucoma and 205 patients without glaucoma participated in 4 experiments. The GQL-15 summary scores are statistically different between patients with and without glaucoma (standard mean difference [SMD] = 0.94, 95% confidence interval [CI]: 0.73-1.16, P < .01). GQL-15 summary scores for patients with mild, moderate, and severe visual field loss all differed significantly from those of patients without glaucoma; the SMDs for their summary scores were as follows: mild: 1.24, 95% CI: 0.26 to 2.22, P = .01; moderate: 2.05, 95% CI: 0.91 to 3.19, P < .001; and severe: 2.57, 95% CI: 1.44 to 3.71, P < .001. Two factor scores for central and near vision (SMD = -0.35, 95% CI: -1.01 to 0.30, P = .29) and glare and dark adaptation (SMD = -0.36, 95% CI: -1.01 to 0.30, P = .28) did not differ significantly between patients with mild and moderate visual field loss. However, summary scores and 2 factor scores (peripheral vision and outdoor mobility) differed significantly between patients with mild and moderate glaucoma. In addition, summary scores and all 4 factor scores differed significantly between patients with mild and severe glaucoma. Moreover, summary scores and 3 factor scores (peripheral vision, glare and dark adaptation, and outdoor mobility) differed significantly between patients with moderate and severe glaucoma. However, scores for 1 factor (central and near vision) did not differ significantly between any of the patient groups (SDM = -0.53, 95% CI = -1.33 to 0.27, P = .19).
Glaucoma patients with visual field loss showed significantly poorer QoL relative to that of patients without glaucoma. Patients' QoL decreased as their glaucoma severity increased.
我们进行了一项荟萃分析,以确定轻度、中度和重度视野缺损对青光眼患者生活质量(QoL)的影响。
使用PubMed、医学文摘数据库和中国知网数据库进行全面的文献检索,以识别2016年6月30日前发表的相关文章。使用青光眼生活质量-15问卷(GQL-15)测量患者的生活质量。
共有401例青光眼患者和205例非青光眼患者参与了4项实验。青光眼患者和非青光眼患者的GQL-15总分在统计学上有差异(标准均数差[SMD]=0.94,95%置信区间[CI]:0.73-1.16,P<.01)。轻度、中度和重度视野缺损患者的GQL-15总分与非青光眼患者均有显著差异;其总分的SMD如下:轻度:1.24,95%CI:0.26至2.22,P=.01;中度:2.05,95%CI:0.91至3.19,P<.001;重度:2.57,95%CI:1.44至3.71,P<.001。轻度和中度视野缺损患者在中央和近视力(SMD=-0.35,95%CI:-1.01至0.30,P=.29)以及眩光和暗适应(SMD=-0.36,95%CI:-1.01至0.30,P=.28)这两个因子得分上无显著差异。然而,轻度和中度青光眼患者在总分和两个因子得分(周边视力和户外移动性)上有显著差异。此外,轻度和重度青光眼患者在总分和所有四个因子得分上有显著差异。而且,中度和重度青光眼患者在总分和三个因子得分(周边视力、眩光和暗适应以及户外移动性)上有显著差异。然而,在任何患者组中,一个因子(中央和近视力)的得分均无显著差异(SDM=-0.53,95%CI=-1.33至0.27,P=.19)。
与非青光眼患者相比,有视野缺损的青光眼患者生活质量明显较差。随着青光眼严重程度的增加,患者的生活质量下降。